This investigate was performed To guage the likely on the CPPs with tumor-concentrating on Qualities to deliver a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, like a novel therapeutic approach for CXCR4+ HCC cells. T22 was preferred since the nanocarrier https://https-143315-com64196.wizzardsblog.com/31467784/top-guidelines-of-https-1433123-com